Valuation: Sharps Technology, Inc.

Capitalization 77.33M 65.95M 60.49M 57.26M 106M 7.4B 107M 720M 281M 3.51B 290M 284M 12.2B P/E ratio 2024 *
-
P/E ratio 2025 -0.18x
Enterprise value 70.03M 59.73M 54.78M 51.85M 96.1M 6.7B 97.01M 652M 254M 3.18B 263M 257M 11.05B EV / Sales 2024
-
EV / Sales 2025 252,610,484x
Free-Float
15.63%
Yield 2024 *
-
Yield 2025 -
1 day-4.31%
1 week+5.26%
Current month+12.04%
1 month+19.76%
3 months+21.21%
6 months-45.50%
Current year-1.48%
1 week 1.84
Extreme 1.84
2.14
1 month 1.72
Extreme 1.725
2.14
Current year 1.42
Extreme 1.415
2.61
1 year 1.42
Extreme 1.415
18.23
3 years 1.42
Extreme 1.415
7,590.08
5 years 1.42
Extreme 1.415
23,892.26
10 years 1.42
Extreme 1.415
23,892.26
Manager TitleAgeSince
Chief Executive Officer 68 24/08/2025
Director of Finance/CFO 68 16/02/2026
Chief Investment Officer 35 24/08/2025
Director TitleAgeSince
Chairman 71 30/11/2018
Chairman 68 29/06/2025
Director/Board Member 67 31/08/2021
Change 5d. change 1-year change 3-years change Capi.($)
-4.31%+5.26%-57.08%-99.97% 77.33M
+2.17%-3.24%-36.09%-23.66% 147B
+3.06%-1.25%-10.48%-13.57% 98.63B
+1.15%+0.33%+51.44%+79.22% 57.86B
+0.47%-14.70%-6.27%+52.60% 50.77B
+3.05%+2.32%-15.87%-41.58% 40.64B
-1.78%-14.94% - - 32.6B
+3.05%+2.79%-28.11%-49.76% 23.59B
-3.17%+0.68%+42.20%-13.32% 22.05B
+4.46%-1.00%-9.55%0.00% 20.68B
Average +0.71%-2.33%-7.76%-12.23% 49.38B
Weighted average by Cap. +1.45%-3.49%-9.23%-1.57%

Financials

2024 2025
Net sales - 0.2 0.17 0.16 0.15 0.28 19.54 0.28 1.9 0.74 9.27 0.77 0.75 32.2
Net income -9.3M -7.93M -7.27M -6.88M -12.76M -890M -12.88M -86.61M -33.73M -422M -34.88M -34.15M -1.47B -283M -241M -221M -209M -388M -27.04B -391M -2.63B -1.02B -12.83B -1.06B -1.04B -44.56B
Net Debt 2.9M 2.47M 2.27M 2.15M 3.98M 278M 4.02M 27.01M 10.52M 132M 10.88M 10.65M 457M -7.3M -6.22M -5.71M -5.4M -10.01M -699M -10.11M -67.99M -26.48M -331M -27.38M -26.81M -1.15B
Logo Sharps Technology, Inc.
Sharps Technology, Inc. is a medical device and pharmaceutical packaging company. The Company is engaged in offering patented smart-safety syringe products to the healthcare industry. The Company's smart safety syringe products, such as Securgard, Sologard, and Sharps Provensa, are ultra-low waste syringes that incorporate both passive and active safety and reuse prevention features. It Sharps Securegard and Sologard, and Roncadelle SafeR safety syringe product lines incorporate both active and passive safety features and have been designed to address the three primary administration concerns with syringe delivery systems, including accidental needlestick injuries, wasted medicine/dead space and reuse prevention. It also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. It has a manufacturing facility in Hungary and is pursuing plans to expand its manufacturing capacity in the United States.
Employees
-
Date Price Change Volume
12/05/26 2.000 $ -4.31% 247,546
11/05/26 2.090 $ +4.50% 331,347
08/05/26 2.000 $ +6.95% 471,985
07/05/26 1.870 $ -0.53% 148,770
06/05/26 1.880 $ -1.05% 329,639

Annual profits - Rate of surprise